title: Interleukin-2 therapy with or without lymphokine-activated killer-cell infusions for low-grade non-Hodgkin's lymphomas?
authors.forename: R
authors.initials: R
authors.lastname: Levy
authors.forename: J M
authors.initials: JM
authors.lastname: Tourani
authors.forename: J M
authors.initials: JM
authors.lastname: Andrieu
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins